Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Vasc Interv Radiol. 2013 Aug;24(8):1083–1092. doi: 10.1016/j.jvir.2013.04.019

Figure 1.

Figure 1

Targeting the hallmarks of cancer. Drugs that interfere with, or target, the hallmarks of cancer growth, progression, or resistance have been developed. (From Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646–674. Copyright © 2011 Elsevier. Reprinted with permission from Elsevier.)